Inappropriate ADH Syndrome: Clinical Trials

1 trial for Inappropriate ADH Syndrome, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 41Completed 1

Follow Inappropriate ADH Syndrome: new trials by email Literature Review of Inappropriate ADH Syndrome trials Research Report on Inappropriate ADH Syndrome

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Effects of the SGLT2 Inhibitor Empagliflozin in Patients With Euvolemic and Hypervolemic Hyponatremia
Empagliflozin 25 MG, Placebo - Hyponatremia, SIADH
Phase 4CompletedUniversity Hospital, Basel, Switzerland1132021-02-042026-09-22

Narrower conditions

Hyponatremia (1)  ·  Liver Failure (1)  ·  Renal Insufficiency (1)

Broader conditions

Brain Diseases (1)  ·  Central Nervous System Diseases (1)  ·  Digestive System Diseases (1)  ·  Endocrine System Diseases (1)  ·  Female Urogenital Diseases (1)  ·  Female Urogenital Diseases and Pregnancy Complications (1)  ·  Hepatic Insufficiency (1)  ·  Hypothalamic Diseases (1)  ·  Kidney Diseases (1)  ·  Liver Diseases (1)  ·  Male Urogenital Diseases (1)  ·  Metabolic Diseases (1)  ·  Nervous System Diseases (1)  ·  Nutritional and Metabolic Diseases (1)  ·  Pituitary Diseases (1)

Interventions

empagliflozin (1)

Sponsors

University Hospital, Basel, Switzerland (1)

Countries

Germany (1)  ·  Netherlands (1)  ·  Switzerland (1)

Top investigators

Julie Refardt, MD (1)